Back
Noble Corp. Plc Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
42
NE
Noble Corp. Plc
Last Price:
$29.04
Seasonality Move:
5.07%
Sell
38
MNPR
Monopar Therapeutics, Inc.
Last Price:
$66.01
Seasonality Move:
9.84%
Sell
42
Noble Corp. Plc (NE)
is a Sell
Is Noble Corp. Plc a Buy, Sell or Hold?
-
The current Noble Corp. Plc [NE] share price is $28.24. The Score for NE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $65.30. The Score for MNPR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NE Stock Price Chart
What is Noble Corp. Plc's stock price today?
-
The Noble Corp. Plc share price today is $28.24Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NE is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $65.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.62 | Sell |
| Relative Strength Index (14 RSI): | 40.54 | Sell |
| Chaikin Money Flow: | -826944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.21 - 31.77) | Sell |
| Bollinger Bands (100): | (27.78 - 30.66) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.92 | Sell |
| Relative Strength Index (14 RSI): | 34.74 | Sell |
| Chaikin Money Flow: | 193884 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.82 - 81.42) | Sell |
| Bollinger Bands (100): | (48.89 - 89.85) | Sell |
NE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.23 | Buy |
| 20-day SMA: | 29.79 | Sell |
| 50-day SMA: | 29.82 | Sell |
| 200-day SMA: | 27.18 | Buy |
| 8-day EMA: | 28.42 | Sell |
| 20-day EMA: | 29.12 | Sell |
| 50-day EMA: | 29.47 | Sell |
| 200-day EMA: | 29.22 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.19 | Sell |
| 20-day SMA: | 72.23 | Sell |
| 50-day SMA: | 78.7 | Sell |
| 200-day SMA: | 53.66 | Buy |
| 8-day EMA: | 67.77 | Sell |
| 20-day EMA: | 71.75 | Sell |
| 50-day EMA: | 74.63 | Sell |
| 200-day EMA: | 57.45 | Buy |
Noble Corp. Plc Earnings Growth & NE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $1.39 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.34 per share.
Noble Corp. Plc Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||